How has been the historical performance of Metropolis Healt?
Metropolis Healt has shown consistent growth in net sales and profits, with net sales reaching 1,331.20 Cr in March 2025, up from 1,207.71 Cr in March 2024. Key financial metrics, including operating profit and earnings per share, have also improved, indicating strong operational performance and profitability.
Answer:The historical performance of Metropolis Healt shows a consistent growth in net sales and profits over the years, with net sales reaching 1,331.20 Cr in March 2025, up from 1,207.71 Cr in March 2024 and 1,148.21 Cr in March 2023. The total operating income followed a similar trend, increasing to 1,331.20 Cr in March 2025 from 1,207.71 Cr in March 2024. The company's total expenditure also rose, amounting to 1,028.21 Cr in March 2025, compared to 925.13 Cr in March 2024. Operating profit, excluding other income, was 302.99 Cr in March 2025, slightly up from 282.58 Cr in March 2024, while the overall operating profit stood at 318.10 Cr in March 2025. Profit before tax increased to 190.85 Cr in March 2025 from 174.69 Cr in March 2024, and profit after tax rose to 145.51 Cr from 128.46 Cr in the same period. The earnings per share (EPS) also showed an upward trend, reaching 27.99 in March 2025, compared to 24.94 in March 2024.Breakdown:
Metropolis Healt has demonstrated a robust growth trajectory in its financial performance over the years. The net sales have consistently increased, reflecting a strong operational performance, with the latest figure of 1,331.20 Cr in March 2025 marking a significant rise from previous years. The total operating income mirrored this growth, indicating effective revenue generation strategies. Despite rising total expenditures, the company managed to maintain a healthy operating profit, which slightly increased to 302.99 Cr in March 2025. Profit before tax and profit after tax also saw improvements, showcasing the company's ability to enhance its profitability. The earnings per share have shown a positive trend, further emphasizing the company's strong financial health and operational efficiency. Overall, Metropolis Healt's financial metrics indicate a solid performance with a promising outlook.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
